BERKELEY HEIGHTS, N.J., Oct. 8 /PRNewswire/ -- Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the relocation of its corporate headquarters to accommodate the company’s significant growth and plans for future expansion. The new, larger facility is located in Bedminster, New Jersey.
“Our new headquarters, combined with our recent expansion of operations in Raleigh, North Carolina and Dusseldorf, Germany, offers many advantages to Clinsys and our sponsors,” said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, “The relocation strategically keeps Clinsys in the center of one of the largest biopharmaceutical clusters and experienced employee pools in the country. Our new headquarters will afford us enhanced operational performance from which to continue to provide exceptional service to our existing and new sponsors.”
Clinsys will occupy the new facility on Monday, October 15. The new address is:
One Crossroads Drive, Building A, Second Floor, Bedminster, New Jersey 07921.
About Clinsys Clinical Research, Inc.
Clinsys Clinical Research, Inc.(R), is a therapeutically focused clinical research organization and a Jubilant Organosys company, headquartered in Bedminster, New Jersey. Clinsys has operations in Raleigh, North Carolina; Philadelphia, Pennsylvania; Dusseldorf, Germany; Gent, Belgium; Noida and Bangalore, India. Clinsys provides pharmaceutical and biotechnology companies a broad range of clinical research services in support of Phase I -- IV drug development: project management, medical and clinical monitoring, investigator and patient recruitment, site management, biostatistics, data management, drug safety, quality assurance, regulatory affairs and medical writing services. Clinsys has expertise in a wide range of highly specialized therapeutic areas including oncology, cardiovascular, central nervous system, dermatology, respiratory, and allergy/immunology. Clinsys Clinical Research, Ltd., located in Noida, India, provides extensive clinical research services for Phase I -- IV drug development, and operates a clinical pharmacology unit which performs bioavailability and bioequivalence studies as well as bioanalytical sample analysis, clinical laboratory and pathology services. Targeted Clinical Staffing Solutions(R) (TCSS -- gotcss.com), a division of Clinsys Clinical Research, Inc., is a provider of professional staffing solutions and innovative partnering programs for the life sciences industry. For more information visit clinsyscro.com.
About Jubilant Organosys, Ltd.
Jubilant Organosys is an integrated pharmaceutical services provider, one of the largest custom research and manufacturing services (CRAMS), drug discovery and development services companies headquartered in India. Jubilant Organosys has more than 4,300 employees across organizations in India, the United States, Europe and China. It has four manufacturing locations in India and two in the United States. For more information visit jubl.com.
Clinsys Clinical Research and Targeted Clinical Staffing Solutions are registered trademarks of Clinsys Clinical Research, Inc.
Contact: Colin Coffua -- Vice President, Global Marketing
+1 908 464 7500
ccoffua@clinsyscro.com
CONTACT: Colin Coffua, Vice President, Global Marketing of Clinsys
Clinical Research, Inc. +1-908-464-7500, ccoffua@clinsyscro.com
Web site: http://www.clinsyscro.com/
http://gotcss.com/
http://jubl.com/
